Blog

Peptide research, protocols, and community insights.

The First GLP-1 Pill You Can Take Any Time: Lilly's Foundayo Is Here

The First GLP-1 Pill You Can Take Any Time: Lilly's Foundayo Is Here

On April 1, 2026, the FDA approved Foundayo, a daily weight loss pill from Eli Lilly. It is the firs…

Ryan Mercer·
BPC-157 and TB-500: Why the Healing Hype Is Running Ahead of the Proof

BPC-157 and TB-500: Why the Healing Hype Is Running Ahead of the Proof

BPC-157 and TB-500 are pitched online as near-magic fixes for injured tendons, joints, and guts. But…

Dr. Anna Chereshnevskyi·
Telomeres, Sleep, and Hype: A Plain Look at Longevity Peptides Like Epitalon

Telomeres, Sleep, and Hype: A Plain Look at Longevity Peptides Like Epitalon

Epitalon, MOTS-c, and NAD+ get sold online as an anti-aging stack that slows the clock. The biology…

Dr. Anna Chereshnevskyi·
Five Big Drug Results in Four Days: What the ADA 2026 Meeting Told Us

Five Big Drug Results in Four Days: What the ADA 2026 Meeting Told Us

The American Diabetes Association meeting ran from June 5 to 8 in New Orleans, and it was a packed w…

Ryan Mercer·
A Lab-Tested BPC-157 Just Launched: What It Says About the Research Peptide Market

A Lab-Tested BPC-157 Just Launched: What It Says About the Research Peptide Market

On June 9, 2026, Koi Peptides released a BPC-157 reference compound for lab use, with a certificate…

Ryan Mercer·
Retatrutide Goes the Distance: The Full Phase 3 Diabetes Data Is Here

Retatrutide Goes the Distance: The Full Phase 3 Diabetes Data Is Here

At the ADA 2026 meeting, Eli Lilly shared the first full Phase 3 results for retatrutide in people w…

Dr. Anna Chereshnevskyi·
Once a Month Instead of Once a Week: Inside Pfizer's New GLP-1 Results

Once a Month Instead of Once a Week: Inside Pfizer's New GLP-1 Results

At the ADA meeting on June 6, Pfizer showed off VESPER-3 results for a long-acting GLP-1 shot that o…

Ryan Mercer·
Hims and Hers Shares Jump 49% in a Week on Peptide Pipeline and Novo Nordisk Deal

Hims and Hers Shares Jump 49% in a Week on Peptide Pipeline and Novo Nordisk Deal

Hims and Hers stock surged 49% over five sessions as investors reacted to renewed FDA interest in pe…

Ryan Mercer·
Croda Upgrades Matrixyl with New Encapsulation Peptide Technology

Croda Upgrades Matrixyl with New Encapsulation Peptide Technology

Croda has unveiled Matrixyl Neolide, a next-generation evolution of the iconic Matrixyl peptide comp…

Ryan Mercer·
12 Peptides Could Return to Legal Compounding — FDA Sets Review Timeline

12 Peptides Could Return to Legal Compounding — FDA Sets Review Timeline

The FDA has scheduled two advisory committee meetings to decide whether a dozen peptides should be a…

Dr. Anna Chereshnevskyi·
Stanford Found a Tiny Peptide That Cuts Appetite Like Ozempic — Without the Nausea

Stanford Found a Tiny Peptide That Cuts Appetite Like Ozempic — Without the Nausea

Stanford researchers used AI to discover BRP, a naturally occurring 12-amino-acid peptide that suppr…

Dr. Anna Chereshnevskyi·
What Peptides Are FDA Approved?

What Peptides Are FDA Approved?

A complete list of FDA-approved peptide drugs — including GLP-1 agonists, hormones, and specialty me…

Dr. Anna Chereshnevskyi·
Are Peptides Safe?

Are Peptides Safe?

Safety varies enormously by peptide, dose, route, and sourcing. Here is an honest breakdown of what…

Dr. Anna Chereshnevskyi·
Are Peptides FDA Approved?

Are Peptides FDA Approved?

Most peptides used in research and wellness are not FDA approved. Here is what that actually means,…

Dr. Anna Chereshnevskyi·